Agenus Newsroom

H.C. Wainwright Maintains Agenus(AGEN.US) With Hold Rating

Futu NewsDec 6 01:35

Agenus Analyst Ratings

BenzingaNov 29 17:44

H.C. Wainwright Maintains Agenus(AGEN.US) With Hold Rating, Maintains Target Price $7

Futu NewsNov 28 01:31

Cautious Hold Rating on Agenus Amid Strategic Realignment and Financial Challenges

TipRanksNov 28 01:28

Analysts Offer Insights on Healthcare Companies: Nkarta (NKTX), Agenus (AGEN) and SAGE Therapeutics (SAGE)

TipRanksNov 25 14:15

B.Riley Financial Maintains Agenus(AGEN.US) With Buy Rating, Cuts Target Price to $11

Futu NewsNov 19 16:40

B. Riley Adjusts Agenus Price Target to $11 From $18, Maintains Buy Rating

MT NewswiresNov 18 21:50

Promising Developments and Strategic Financing Enhance Agenus's Buy Rating Amidst Stock Volatility

TipRanksNov 18 20:47

Agenus Is Maintained at Neutral by HC Wainwright & Co.

Dow JonesNov 13 00:13

Agenus Analyst Ratings

BenzingaNov 13 00:06

H.C. Wainwright Maintains Agenus(AGEN.US) With Hold Rating, Cuts Target Price to $7

Futu NewsNov 12 23:32

Agenus Analyst Ratings

BenzingaAug 14 21:29

B. Riley Adjusts Price Target on Agenus to $18 From $42, Maintains Buy Rating

MT NewswiresAug 14 19:59

B.Riley Financial Maintains Agenus(AGEN.US) With Buy Rating, Cuts Target Price to $18

Futu NewsAug 14 02:31

Agenus Hold Rating: Balancing Phase 2 Progress With Regulatory Challenges and Uncertainty

TipRanksAug 8 23:39

Jefferies Downgrades Agenus to Hold, Raises Price Target to $7

BenzingaJul 20 05:17

Agenus Downgraded at Baird After FDA Feedback on Cancer Drug

Seeking AlphaJul 19 21:12

HC Wainwright Downgrades Agenus to Neutral From Buy, Adjusts Price Target to $9 From $40

MT NewswiresJul 19 19:08

Hold Rating Justified for Agenus Amidst Regulatory Uncertainties and Mixed Clinical Results

TipRanksJul 19 16:29

HC Wainwright & Co. Downgrades Agenus to Neutral, Lowers Price Target to $9

BenzingaJul 19 00:39